Reply to the comments on “Five‐repetition sit‐to‐stand test: End with the fifth stand or sit?”

Yamada, Minoru; Lim, Jae‐Young; Assantachai, Prasert; Tanaka, Tomoki; Kim, Miji; Lee, Sang Yoon; Lim, Wee-Shiong; Arai, Hidenori

doi:10.1111/ggi.14395

Cited by 2 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results indicated that using the standing endpoint resulted in a screening criterion of 11.1 seconds, whereas using sitting as the endpoint yielded a criterion of 11.7 seconds. 40 )…”

Section: Factors Influencing Measurement Resultsmentioning

confidence: 99%

“…The results indicated that using the standing endpoint resulted in a screening criterion of 11.1 seconds, whereas using sitting as the endpoint yielded a criterion of 11.7 seconds. 40) Finally, the use of digital equipment must be considered. When performing the STST, the state of standing from a seated position is monitored using a load cell and a light detection and ranging (LiDAR) sensor on the chair, allowing for the verification of the total number of stand-up and sit-down cycles.…”

Section: Factors Influencing Measurement Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Comprehensive Assessment of Lower Limb Function and Muscle Strength in Sarcopenia: Insights from the Sit-to-Stand Test

Park,

Shin

2024

Ann Geriatr Med Res

View full text Add to dashboard Cite

The sit-to-stand test is an essential tool used to assess lower limb function and muscle strength in older adults and various patient populations, and also plays a role in sarcopenia screening. Among its forms, the five-time sit-to-stand test (FTSST) is widely used, with previous studies suggesting cutoff values of >10 seconds and >11 seconds for the sitting-to-standing and standing-to-sitting transitions, respectively. The 30-second and 1-minute sit-to-stand tests (30STS and 1MSTS, respectively) also provide comprehensive assessments. While much of the current research on sarcopenia focuses on the FTSST, there is a burgeoning need for an in-depth exploration of the 30STS and 1MSTS. Studies on these tests are vital to refine the criteria for sarcopenia, establish accurate cutoff values, and enhance diagnostic precision and treatment effectiveness. This need highlights the importance of further research into the 30STS and 1MSTS for refining the diagnostic criteria for sarcopenia.

show abstract

“…The results indicated that using the standing endpoint resulted in a screening criterion of 11.1 seconds, whereas using sitting as the endpoint yielded a criterion of 11.7 seconds. 40 )…”

Section: Factors Influencing Measurement Resultsmentioning

confidence: 99%

Section: Factors Influencing Measurement Resultsmentioning

confidence: 99%

Comprehensive Assessment of Lower Limb Function and Muscle Strength in Sarcopenia: Insights from the Sit-to-Stand Test

Park,

Shin

2024

Ann Geriatr Med Res

View full text Add to dashboard Cite

show abstract

“…Either the stand or sit stop can be used, as long as the same protocol is consistently used. 25 AWGS 2019 recommends ≥12 seconds as the cutoff for low physical performance to corresponded to a walking speed of 1.0 m/s. 1 The 6-m usual gait speed test involves measuring the time taken to walk 6 m at a normal pace from a moving start, without deceleration, and taking the average result of at least two trials as the recorded speed.…”

Section: Physical Performancementioning

confidence: 99%

Singapore Clinical Practice Guidelines for Sarcopenia: Screening, Diagnosis, Management, and Prevention

Lim

2023

SFP

View full text Add to dashboard Cite

Sarcopenia refers to the age-associated progressive and generalised loss of skeletal muscle mass plus loss of muscle strength and/or reduced physical performance. Despite its importance, sarcopenia often remains unrecognised and inadequately managed in routine clinical care. A workgroup was convened by the Chapter of Geriatricians and the Society for Geriatric Medicine Singapore to develop the first-ever country-specific CPG for sarcopenia. The workgroup developed 20 evidence-based recommendations that aim to facilitate adoption of the Asian Working Group for Sarcopenia (AWGS) 2019 consensus into current practice in Singapore. The CPG recommends a case-finding approach in atrisk older adults using validated case-finding tools. Screen-positive individuals should be assessed for “possible sarcopenia” and underlying causes. For diagnosis, the CPG recommends using the AWGS 2019 algorithm, and when necessary, dual-energy X-ray absorptiometry to determine low lean mass for a confirmatory diagnosis of sarcopenia. For treatment, the CPG recommends resistance exercises and a quality protein-rich diet/protein supplementation, with Vitamin D supplementation for insufficiency (<30 micrograms/L). For prevention, the CPG recommends regular resistance-based physical activity and adequate protein intake (≥1.0g/kg bodyweight). We encourage more research to address local evidence gaps. It is hoped that this first country-specific CPG for sarcopenia will play a big role in facilitating the adoption of the AWGS 2019 consensus into current practice in Singapore.

show abstract

Reply to the comments on “Five‐repetition sit‐to‐stand test: End with the fifth stand or sit?”

Cited by 2 publications

References 2 publications

Comprehensive Assessment of Lower Limb Function and Muscle Strength in Sarcopenia: Insights from the Sit-to-Stand Test

Comprehensive Assessment of Lower Limb Function and Muscle Strength in Sarcopenia: Insights from the Sit-to-Stand Test

Singapore Clinical Practice Guidelines for Sarcopenia: Screening, Diagnosis, Management, and Prevention

Contact Info

Product

Resources

About